Table 1.
Characteristic | Training cohort (n = 267) | Testing cohort (n = 246) | Entire cohort (n = 513) | |||
---|---|---|---|---|---|---|
Number | % | Number | % | Number | % | |
Age (years) | ||||||
≤65 | 174 | 65.2 | 164 | 66.7 | 338 | 65.9 |
>65 | 93 | 34.8 | 82 | 33.3 | 175 | 34.1 |
Gender | ||||||
Male | 185 | 69.3 | 151 | 61.4 | 336 | 65.5 |
Female | 82 | 30.7 | 95 | 38.6 | 177 | 34.5 |
Pathological stage | ||||||
Stage I | 137 | 51.3 | 118 | 48.0 | 255 | 49.7 |
Stage II | 30 | 11.2 | 24 | 9.8 | 54 | 10.5 |
Stage III | 58 | 21.8 | 64 | 26.0 | 122 | 23.8 |
Stage IV | 42 | 15.7 | 40 | 16.2 | 82 | 16.0 |
Histological grade | ||||||
G1 | 8 | 3.0 | 5 | 2.0 | 13 | 2.5 |
G2 | 109 | 40.8 | 114 | 46.3 | 223 | 43.5 |
G3 | 110 | 41.2 | 94 | 28.2 | 204 | 39.8 |
G4 | 40 | 15.0 | 33 | 13.5 | 73 | 14.2 |
T stage | ||||||
T1 | 141 | 52.8 | 120 | 48.8 | 261 | 50.9 |
T2 | 38 | 14.2 | 28 | 11.4 | 66 | 12.9 |
T3 | 83 | 31.1 | 92 | 37.4 | 175 | 34.1 |
T4 | 5 | 1.9 | 6 | 2.4 | 11 | 2.1 |
N stage | ||||||
N0 | 122 | 45.7 | 112 | 45.5 | 234 | 45.6 |
N1 | 9 | 3.4 | 5 | 2.0 | 14 | 2.7 |
Nx | 136 | 50.9 | 129 | 45.5 | 265 | 51.7 |
M stage | ||||||
M0 | 214 | 80.1 | 196 | 79.7 | 410 | 79.9 |
M1 | 40 | 15.0 | 37 | 15.0 | 77 | 15.0 |
Mx | 13 | 4.9 | 13 | 5.3 | 26 | 5.1 |
Outcome | ||||||
Alive | 189 | 70.8 | 162 | 65.9 | 351 | 68.4 |
Dead | 78 | 29.2 | 84 | 34.1 | 162 | 31.6 |